FTC Plans Crackdown on Marketing Claims of OTC Homeopathic Drugs
Regulatory Affairs Professionals Society
The Federal Trade Commission (FTC) on Tuesday announced a new enforcement policy that will hold efficacy and safety claims for OTC homeopathic drugs to the same standard as other products making similar claims.
The policy was informed by an FTC workshop held last year to examine how such drugs are marketed to consumers. The FTC also released its staff report on the workshop, which summarizes the panel presentations and related public comments in addition to describing consumer research commissioned by the FTC.
“Companies must have competent and reliable scientific evidence for health-related claims, including claims that a product can treat specific conditions,” FTC said.